Pricing

Log inSign up

Acumen Pharmaceuticals

1 follower

‌

Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Industries

Pharmaceutical

Headquarters

Charlottesville, United States

Employees

11-50

Links

Org chart

Daniel O’Connell
President & CEO
Collapse
Russell Barton
Chief Operating Officer
Matthew Zuga
CFO & Chief Business Officer
Eric Siemers
Chief Medical Officer
Derek Meisner
Chief Legal Officer
Julie Bockenstette
EVP & Head of Human Resources
Alex Braun
VP, Head of Investor Relations
Jerry Moore
Senior Advisor, Nonclinical Development

Board & advisors

Jeffrey L. Ives
Director
Sean Stalfort
Director
Laura Stoppel
Director
KD
Kim Drapkin
Board Member
DP
Derrell D. Porter
Board Member
NF
Nathan B. Fountain
Board Member
LM
Lennart Mucke
Advisor
JC
Jeffrey Cummings
Scientific Advisor
SD
Steven DeKosky
Scientific Advisor
WK
William Klein
Scientific Advisor
GK
Grant Krafft
Scientific Advisor
CL
Cynthia Lemere
Scientific Advisor
CM
Colin Masters
Scientific Advisor
SS
Stephen Salloway
Scientific Advisor
RS
Reisa Sperling
Scientific Advisor
MW
Michael Weiner
Scientific Advisor

Teams

JC
SD
+15

Research and Development

19 people · 0 jobs

+3

Clinical Operations Team

7 people · 0 jobs

Leadership Team

4 people · 0 jobs

Medical and Legal Affairs

4 people · 0 jobs

Finance and Accounting

3 people · 0 jobs

Offices

Similar companies

Arthritis Knee Pain Centers

2 followers

Bristol-Myers Squibb

250 followers

NYU Langone Health

24 followers

West Pharmaceutical Services

8 followers

Curia Global

6 followers

AbbVie

269 followers

Navitus Health

3 followers

HistoSonics

3 followers

Xeris Pharmaceuticals

2 followers

Corcept Therapeutics

4 followers

Rocket Pharmaceuticals

3 followers

Explore companies